Description
IGF::CT::IGF XENAZINE 25MG RX FILL.
First action · last action
2013-05-17 · 2013-05-17
Transactions
1
First transaction's obligation
$3,218
Base + all options value (sum of deltas)
$3,218
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797BP0418
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-05-17+$3,218= $3,218
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-05-17 | +$3,218 | $3,218 | IGF::CT::IGF XENAZINE 25MG RX FILL. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI F1M3L99R99B3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0172 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24920N0537 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $25,476 | FY2020 |
| 36C24920N0520 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $20,381 | FY2020 |
| 36C24920N0515 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
| 36C24920N0502 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
| 36C24920N0482 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
Other recipients under 6505 from 618-MINNEAPOLIS VA MEDICAL CENTER (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA26316E0587 | MCKESSON CORPORATION | 618-MINNEAPOLIS VA MEDICAL CENTER | $11,602,626 | FY2016 |
| VA26316E0586 | MCKESSON CORPORATION | 618-MINNEAPOLIS VA MEDICAL CENTER | $7,713,803 | FY2016 |
| VA26316E0442 | MCKESSON CORPORATION | 618-MINNEAPOLIS VA MEDICAL CENTER | $7,309,602 | FY2016 |
| VA26316E0132 | MCKESSON CORPORATION | 618-MINNEAPOLIS VA MEDICAL CENTER | $7,862,529 | FY2016 |
| VA26316E0111 | MCKESSON CORPORATION | 618-MINNEAPOLIS VA MEDICAL CENTER | $5,614,469 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26313J1584_3600_VA797BP0418_3600 · retrieved 2026-09-26.